PTPRC and neoplasm: We found that as early as the first week after tumor implantation, there were infiltrating CD45+ immune cells, mainly in the tumor-side (ipsilateral) right hemisphere (RH), compared with the contralateral left hemisphere (LH), and these infiltrates continued to increase over time following GBM engraftment (Figure 1D, Supplementary Figure S1C).